{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:33Z","timestamp":1761561873037},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-8722-7-43","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T01:01:27Z","timestamp":1401670887000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding"],"prefix":"10.1186","volume":"7","author":[{"given":"Agnieszka","family":"Dzikiewicz-Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Macieja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Ma\u0142y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Januszkiewicz-Lewandowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mosor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,2]]},"reference":[{"key":"401_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 2009, 136: 215-233. 10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"401_CR2","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S: miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014, 42: D68-D73. 10.1093\/nar\/gkt1181.","journal-title":"Nucleic Acids Res"},{"key":"401_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19: 92-105.","journal-title":"Genome Res"},{"key":"401_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009, 10: 704-714. 10.1038\/nrg2634.","journal-title":"Nat Rev Genet"},{"key":"401_CR5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/leu.2008.382","volume":"23","author":"S Yendamuri","year":"2009","unstructured":"Yendamuri S, Calin GA: The role of microRNA in human leukemia: a review. Leukemia. 2009, 23: 1257-1263. 10.1038\/leu.2008.382.","journal-title":"Leukemia"},{"key":"401_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.critrevonc.2009.05.001","volume":"74","author":"H Zhao","year":"2010","unstructured":"Zhao H, Wang D, Du W, Gu D, Yang R: MicroRNA and leukemia: tiny molecule, great function. Crit Rev Oncol Hematol. 2010, 74: 149-155. 10.1016\/j.critrevonc.2009.05.001.","journal-title":"Crit Rev Oncol Hematol"},{"key":"401_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13402-012-0095-3","volume":"35","author":"S Babashah","year":"2012","unstructured":"Babashah S, Sadeghizadeh M, Tavirani MR, Farivar S, Soleimani M: Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell Oncol (Dordr). 2012, 35: 317-334. 10.1007\/s13402-012-0095-3.","journal-title":"Cell Oncol (Dordr)"},{"key":"401_CR8","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa050995","volume":"353","author":"GA Calin","year":"2005","unstructured":"Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005, 353: 1793-1801. 10.1056\/NEJMoa050995.","journal-title":"N Engl J Med"},{"key":"401_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/gcc.20709","volume":"48","author":"V Fulci","year":"2009","unstructured":"Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Fo\u00e0 R, Macino G: Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer. 2009, 48: 1069-1082. 10.1002\/gcc.20709.","journal-title":"Genes Chromosomes Cancer"},{"key":"401_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3324\/haematol.2010.026138","volume":"96","author":"D Schotte","year":"2011","unstructured":"Schotte D, De Menezes RX, Akbari Moqadam F, Khankahdani LM, Lange-Turenhout E, Chen C, Pieters R, Den Boer ML: MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011, 96: 703-1071. 10.3324\/haematol.2010.026138.","journal-title":"Haematologica"},{"key":"401_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1476-4598-8-69","volume":"8","author":"E San Jos\u00e9-En\u00e9riz","year":"2009","unstructured":"San Jos\u00e9-En\u00e9riz E, Rom\u00e1n-G\u00f3mez J, Jim\u00e9nez-Velasco A, Garate L, Martin V, Cordeu L, Vilas-Zornoza A, Rodr\u00edguez-Otero P, Calasanz MJ, Pr\u00f3sper F, Agirre X: MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Mol Cancer. 2009, 8: 69-10.1186\/1476-4598-8-69.","journal-title":"Mol Cancer"},{"key":"401_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2010-09-191312","volume":"117","author":"G Marcucci","year":"2011","unstructured":"Marcucci G, Mr\u00f3zek K, Radmacher MD, Garzon R, Bloomfield CD: The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011, 117: 1121-1129. 10.1182\/blood-2010-09-191312.","journal-title":"Blood"},{"key":"401_CR13","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.febslet.2010.08.009","volume":"585","author":"SA Melo","year":"2011","unstructured":"Melo SA, Esteller M: Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011, 585: 2087-2099. 10.1016\/j.febslet.2010.08.009.","journal-title":"FEBS Lett"},{"key":"401_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pharmthera.2012.08.016","volume":"137","author":"DW Salzman","year":"2013","unstructured":"Salzman DW, Weidhaas JB: SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther. 2013, 137: 55-63. 10.1016\/j.pharmthera.2012.08.016.","journal-title":"Pharmacol Ther"},{"key":"401_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2217\/14622416.10.3.399","volume":"10","author":"PJ Mishra","year":"2009","unstructured":"Mishra PJ, Bertino JR: MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics. 2009, 10: 399-416. 10.2217\/14622416.10.3.399.","journal-title":"Pharmacogenomics"},{"key":"401_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3324\/haematol.2012.073015","volume":"98","author":"CK Cheng","year":"2013","unstructured":"Cheng CK, Kwan TK, Cheung CY, Ng K, Liang P, Cheng SH, Chan NP, Ip RK, Wong RS, Lee V, Li CK, Yip SF, Ng MH: A polymorphism in the 3\u2032-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemia. Haematologica. 2013, 98: 913-917. 10.3324\/haematol.2012.073015.","journal-title":"Haematologica"},{"key":"401_CR17","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","volume":"2","author":"B John","year":"2004","unstructured":"John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS: Human MicroRNA targets. PLoS Biol. 2004, 2: e363-10.1371\/journal.pbio.0020363.","journal-title":"PLoS Biol"},{"key":"401_CR18","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ng2135","volume":"39","author":"M Kertesz","year":"2007","unstructured":"Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E: The role of site accessibility in microRNA target recognition. Nat Genet. 2007, 39: 1278-1284. 10.1038\/ng2135.","journal-title":"Nat Genet"},{"key":"401_CR19","doi-asserted-by":"publisher","first-page":"D640","DOI":"10.1093\/nar\/gkp926","volume":"38","author":"S Hiard","year":"2010","unstructured":"Hiard S, Charlier C, Coppieters W, Georges M, Baurain D: Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res. 2010, 38: D640-D651. 10.1093\/nar\/gkp926.","journal-title":"Nucleic Acids Res"},{"key":"401_CR20","doi-asserted-by":"publisher","first-page":"D51","DOI":"10.1093\/nar\/gkl797","volume":"35","author":"L Bao","year":"2007","unstructured":"Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y: PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res. 2007, 35: D51-D54. 10.1093\/nar\/gkl797.","journal-title":"Nucleic Acids Res"},{"key":"401_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/carcin\/bgr272","volume":"33","author":"L Yang","year":"2012","unstructured":"Yang L, Li Y, Cheng M, Huang D, Zheng J, Liu B, Ling X, Li Q, Zhang X, Ji W, Zhou Y, Lu J: A functional polymorphism at microRNA-629-binding site in the 3\u2032-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis. 2012, 33: 338-347. 10.1093\/carcin\/bgr272.","journal-title":"Carcinogenesis"},{"key":"401_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/bioinformatics\/btp649","volume":"26","author":"W Ritchie","year":"2010","unstructured":"Ritchie W, Flamant S, Rasko JE: mimiRNA: a microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets. Bioinformatics. 2010, 26: 223-227. 10.1093\/bioinformatics\/btp649.","journal-title":"Bioinformatics"},{"key":"401_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cca.2012.03.007","volume":"413","author":"PC Lin","year":"2012","unstructured":"Lin PC, Liu TC, Chang CC, Chen YH, Chang JG: High-resolution melting (HRM) analysis for the detection of single nucleotide polymorphisms in microRNA target sites. Clin Chim Acta. 2012, 413: 1092-1097. 10.1016\/j.cca.2012.03.007.","journal-title":"Clin Chim Acta"},{"key":"401_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/carcin\/bgr300","volume":"33","author":"MT Teo","year":"2012","unstructured":"Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, Hall J, Landi S, Bishop DT, Kiltie AE: The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis. 2012, 33: 581-586. 10.1093\/carcin\/bgr300.","journal-title":"Carcinogenesis"},{"key":"401_CR25","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/carcin\/bgr209","volume":"32","author":"Z Liu","year":"2011","unstructured":"Liu Z, Wei S, Ma H, Zhao M, Myers JN, Weber RS, Sturgis EM, Wei Q: A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2011, 32: 1668-1674. 10.1093\/carcin\/bgr209.","journal-title":"Carcinogenesis"},{"key":"401_CR26","doi-asserted-by":"publisher","first-page":"8535","DOI":"10.1158\/0008-5472.CAN-08-2129","volume":"68","author":"LJ Chin","year":"2008","unstructured":"Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R, Zelterman D, Kidd KK, Zhu Y, Christiani DC, Belinsky SA, Slack FJ, Weidhaas JB: A SNP in a let-7 microRNA complementary site in the KRAS 3\u2032 untranslated region increases non-small cell lung cancer risk. Cancer Res. 2008, 68: 8535-8540. 10.1158\/0008-5472.CAN-08-2129.","journal-title":"Cancer Res"},{"key":"401_CR27","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1128\/MCB.16.6.3169","volume":"16","author":"JD Hildebrand","year":"1996","unstructured":"Hildebrand JD, Taylor JM, Parsons JT: An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol. 1996, 16: 3169-3178.","journal-title":"Mol Cell Biol"},{"key":"401_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/emboj\/20.4.755","volume":"20","author":"E Sahai","year":"2001","unstructured":"Sahai E, Olson MF, Marshall CJ: Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 2001, 20: 755-766. 10.1093\/emboj\/20.4.755.","journal-title":"EMBO J"},{"key":"401_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.bjc.6602939","volume":"94","author":"SE Bojesen","year":"2006","unstructured":"Bojesen SE, Ammerpohl O, Weinh\u00e4usl A, Haas OA, Mettal H, Bohle RM, Borkhardt A, Fuchs U: Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome. Br J Cancer. 2006, 94: 323-332. 10.1038\/sj.bjc.6602939.","journal-title":"Br J Cancer"},{"key":"401_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.leukres.2010.10.013","volume":"35","author":"J Qian","year":"2011","unstructured":"Qian J, Qian Z, Lin J, Yao DM, Chen Q, Li Y, Ji RB, Yang J, Xiao GF, Wang YL: Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia. Leuk Res. 2011, 35: 783-786. 10.1016\/j.leukres.2010.10.013.","journal-title":"Leuk Res"},{"key":"401_CR31","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","volume":"19","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Seto M: A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia. 2005, 19: 2013-2016. 10.1038\/sj.leu.2403942.","journal-title":"Leukemia"},{"key":"401_CR32","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-11-0224","volume":"17","author":"AJ Alencar","year":"2011","unstructured":"Alencar AJ, Malumbres R, Kozloski GA, Advani R, Talreja N, Chinichian S, Briones J, Natkunam Y, Sehn LH, Gascoyne RD, Tibshirani R, Lossos IS: MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res. 2011, 17: 4125-4135. 10.1158\/1078-0432.CCR-11-0224.","journal-title":"Clin Cancer Res"},{"key":"401_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12026-008-8055-8","volume":"43","author":"H Wang","year":"2009","unstructured":"Wang H, Morse HC: IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol Res. 2009, 43: 109-117. 10.1007\/s12026-008-8055-8.","journal-title":"Immunol Res"},{"key":"401_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)81348-3","volume":"87","author":"T Holtschke","year":"1996","unstructured":"Holtschke T, L\u00f6hler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring JF, Bachmann MF, Zinkernagel RM, Morse HC, Ozato K, Horak I: Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 1996, 87: 307-317. 10.1016\/S0092-8674(00)81348-3.","journal-title":"Cell"},{"key":"401_CR35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood.V91.1.22","volume":"91","author":"M Schmidt","year":"1998","unstructured":"Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring JF, Rosenbauer F, Huhn D, Wittig B, Horak I, Neubauer A: Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood. 1998, 91: 22-29.","journal-title":"Blood"},{"key":"401_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1084\/jem.190.3.411","volume":"190","author":"L Gabriele","year":"1999","unstructured":"Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P, Giese NA, Ozato K, Morse HC: Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med. 1999, 190: 411-421. 10.1084\/jem.190.3.411.","journal-title":"J Exp Med"},{"key":"401_CR37","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1158\/0008-5472.CAN-10-2493","volume":"71","author":"X Hu","year":"2011","unstructured":"Hu X, Yang D, Zimmerman M, Liu F, Yang J, Kannan S, Burchert A, Szulc Z, Bielawska A, Ozato K, Bhalla K, Liu K: IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 2011, 71: 2882-2891. 10.1158\/0008-5472.CAN-10-2493.","journal-title":"Cancer Res"},{"key":"401_CR38","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1093\/emboj\/16.14.4374","volume":"16","author":"LC Wang","year":"1997","unstructured":"Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH: Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 1997, 16: 4374-4383. 10.1093\/emboj\/16.14.4374.","journal-title":"EMBO J"},{"key":"401_CR39","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1101\/gad.12.15.2392","volume":"12","author":"LC Wang","year":"1998","unstructured":"Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR, Orkin SH: The TEL\/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 1998, 12: 2392-2402. 10.1101\/gad.12.15.2392.","journal-title":"Genes Dev"},{"key":"401_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","volume":"36","author":"E De Braekeleer","year":"2012","unstructured":"De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Basinko A, De Braekeleer M: ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012, 36: 945-961. 10.1016\/j.leukres.2012.04.010.","journal-title":"Leuk Res"},{"key":"401_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cancergencyto.2010.08.004","volume":"203","author":"H Chae","year":"2010","unstructured":"Chae H, Kim M, Lim J, Kim Y, Han K, Lee S: B lymphoblastic leukemia with ETV6 amplification. Cancer Genet Cytogenet. 2010, 203: 284-287. 10.1016\/j.cancergencyto.2010.08.004.","journal-title":"Cancer Genet Cytogenet"},{"key":"401_CR42","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/sj.leu.2403403","volume":"18","author":"L Mauvieux","year":"2004","unstructured":"Mauvieux L, Helias C, Perrusson N, Lioure B, Sorel N, Brizard F, Lessard M: ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts. Leukemia. 2004, 18: 1436-1438. 10.1038\/sj.leu.2403403.","journal-title":"Leukemia"},{"key":"401_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP: A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011, 146: 353-358. 10.1016\/j.cell.2011.07.014.","journal-title":"Cell"},{"key":"401_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/leu.2008.286","volume":"23","author":"D Schotte","year":"2009","unstructured":"Schotte D, Chau JC, Sylvester G, Liu G, Chen C, van der Velden VH, Broekhuis MJ, Peters TC, Pieters R, den Boer ML: Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia. 2009, 23: 313-322. 10.1038\/leu.2008.286.","journal-title":"Leukemia"},{"key":"401_CR45","doi-asserted-by":"publisher","first-page":"e7826","DOI":"10.1371\/journal.pone.0007826","volume":"4","author":"H Zhang","year":"2009","unstructured":"Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J, Zhou H, Qu LH, Xu L, Chen YQ: MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One. 2009, 4: e7826-10.1371\/journal.pone.0007826.","journal-title":"PLoS One"},{"key":"401_CR46","first-page":"1089","volume":"146","author":"CW Roberts","year":"1995","unstructured":"Roberts CW, Sonder AM, Lumsden A, Korsmeyer SJ: Development expression of Hox11 and specification of splenic cell fate. Am J Pathol. 1995, 146: 1089-1101.","journal-title":"Am J Pathol"},{"key":"401_CR47","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1038\/sj.onc.1210766","volume":"26","author":"J O'Neil","year":"2007","unstructured":"O'Neil J, Look AT: Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene. 2007, 26: 6838-6849. 10.1038\/sj.onc.1210766.","journal-title":"Oncogene"},{"key":"401_CR48","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1038\/cddis.2011.122","volume":"3","author":"P Salomoni","year":"2012","unstructured":"Salomoni P, Dvorkina M, Michod D: Role of the promyelocytic leukaemia protein in cell death regulation. Cell Death Dis. 2012, 3: e247-10.1038\/cddis.2011.122.","journal-title":"Cell Death Dis"},{"key":"401_CR49","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/sj.leu.2403367","volume":"18","author":"E Puccetti","year":"2004","unstructured":"Puccetti E, Ruthardt M: Acute promyelocytic leukemia: PML\/RARalpha and the leukemic stem cell. Leukemia. 2004, 18: 1169-1175. 10.1038\/sj.leu.2403367.","journal-title":"Leukemia"},{"key":"401_CR50","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0959-8049(97)10138-1","volume":"34","author":"JY Chan","year":"1998","unstructured":"Chan JY, Chin W, Liew CT, Chang KS, Johnson PJ: Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues. Eur J Cancer. 1998, 34: 1015-1022. 10.1016\/S0959-8049(97)10138-1.","journal-title":"Eur J Cancer"},{"key":"401_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3346\/jkms.2001.16.4.433","volume":"16","author":"GS Yoon","year":"2001","unstructured":"Yoon GS, Yu E: Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis. J Korean Med Sci. 2001, 16: 433-438.","journal-title":"J Korean Med Sci"},{"key":"401_CR52","first-page":"2023","volume":"149","author":"M Gambacorta","year":"1996","unstructured":"Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B, Pacini R, Tanci LN, Pasqualucci L, Ascani S, Mencarelli A, Liso A, Pelicci PG, Falini B: Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol. 1996, 149: 2023-2035.","journal-title":"Am J Pathol"},{"key":"401_CR53","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/bcr3464","volume":"15","author":"QJ Guo","year":"2013","unstructured":"Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, Larue AC, Turner DP, Findlay VJ: MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. Breast Cancer Res. 2013, 15: R70-10.1186\/bcr3464.","journal-title":"Breast Cancer Res"},{"key":"401_CR54","unstructured":"Entrez Gene. [ http:\/\/www.ncbi.nlm.nih.gov\/gene ]"},{"key":"401_CR55","unstructured":"University of California Santa Cruz genome browser. [ http:\/\/genome.ucsc.edu ]"},{"key":"401_CR56","unstructured":"dbSNP. [ http:\/\/www.ncbi.nlm.nih.gov\/projects\/SNP ]"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-7-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T11:38:27Z","timestamp":1597923507000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-7-43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-7-43","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,2]]},"assertion":[{"value":"22 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"43"}}